Dear Shareholders, It has been a while since I provided an update on BioElectronics Corporation’s activities. Below are some of the most significant. Current Medical (RecoveryRx) Sales Although our RecoveryRx product is well accepted in professional practices that offer cash services or products, most medical offices deal strictly with items billable to insurance. Although we … Continue Reading
Author Archives
ianwar@bielcorp.com
BioElectronics Corporation Announces the Publication of Pilot Study ResultsBeneficial Treatment Effect for Phantom and Residual Limb Pain Identified
FREDERICK, MD. February 23, 2024 — (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the publication of a study investigating the treatment of phantom and residual limb pain using its pulsed shortwave therapy device. “Treating intractable postamputation pain with wearable, non-invasive, non-thermal, pulsed shortwave … Continue Reading
BioElectronics Corporation Enters Into a Distribution Agreement For RecoveryRx in Spain With PRIM Group
FREDERICK, MD, April 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced that the Company has entered into a distribution agreement with Madrid / Spain based PRIM Group (www.prim.es) for the distribution of its RecoveryRx device throughout Spain. “PRIM Group in Spain serves as a perfect … Continue Reading
BioElectronics’ RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico
FREDERICK, MD, March 30, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (https://www.bielcorp.com/ (OTC: BIEL) today announced its distribution partner in Mexico has received authorization from Mexican FDA (Cofepris), which allows for the importation of the RecoveryRx® device into Mexico.e Novro Med S.A. de C.V. has contracted for the exclusive distribution rights for RecoveryRx® in Mexico. It is expected … Continue Reading
BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements
February 28, 2022 07:00 ET | Source: BioElectronics Corporation FREDERICK, MD, Feb. 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) is pleased to update, in a letter from its Chairman, Richard Staelin, Ph.D., new distribution partners, personnel changes, and new clinical research studies. SALES UPDATE: BioElectronics Corporation is pleased to announce that it has signed … Continue Reading
BioElectronics Corporation Announces Major Lenders Forgoing Interest for a 3rd Consecutive Year; New Research Projects Underway
Jan 3, 2022 6:01:09 AMOTC Markets Group Inc. News Service — FREDERICK, MD, Jan. 03, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK:BIEL) is pleased to announce that the managers of the firm’s two largest lenders, Ibex LLC and St. John’s LLC, both of which are controlled by Whelan family members, have agreed to forgo … Continue Reading
BioElectronics Corporation Reports Q3 Earnings
Nov. 16, 2021 7:00 AM ETBioElectronics Corporation (BIEL) Year over Year Revenue Growth Exceeds 463% FREDERICK, MARYLAND, Nov. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (BIEL) (https://www.bielcorp.com/ OTC: BIEL) announces a 463% increase in sales revenue resulting in a profitable 3rd quarter. Keeping in line with BIEL’s impressive year-over-year growth, the nine months ended September 30, … Continue Reading
Press Release: BioElectronics Corporation to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com
BioElectronics Corporation to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com Frederick, MD, Oct. 07, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC: BIEL), a leader in the development and manufacturing of non-invasive electroceuticals, today announced that Sree Koneru, Ph.D., will present at the Pain Management Investor Forum to be … Continue Reading
BioElectronics Corporation Discusses Q2 Financials
Revenue Growth Exceeds 665% FREDERICK, MARYLAND, Aug. 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) said today that it would like to clarify information about the Company and acknowledge the investor community’s request for comments following Q2 financials. Key facts from the Q2 financials many of which were found in the footnotes: The … Continue Reading
BioElectronics Corporation Reports Double Digit Quarterly Sales Growth, KT Health and DJO Launches Outpacing Forecasts
Looking ahead, the Company is now working with their three major channel partners, i.e., KT Health and Scott Specialties in the OTC space, and Medi-Launch in the prescription medical market, to solidify new orders after strong initial product launches that took place in Q1 2021.